Laboratory Research Applications
Alphagan P Opthalmic Solution 0.15% is a brimonidine tartrate ophthalmic formulation developed for advanced laboratory research applications. This sterile solution contains 0.15% brimonidine tartrate as the active research compound, enabling researchers to investigate alpha-2 adrenergic receptor mechanisms in controlled experimental settings. The pharmaceutical-grade formulation provides consistent research parameters for studies examining ocular physiology and adrenergic pathway modulation. Our laboratory supply network connects researchers with high-quality compounds through Stroid UK Shop, ensuring reliable access to research-grade materials.
Mechanism and Research Context
Brimonidine tartrate functions as a selective alpha-2 adrenergic receptor agonist, demonstrating high affinity for these receptors in preclinical tissue models. Research applications focus on examining its effects on aqueous humour dynamics, intraocular pressure regulation, and neuroprotective mechanisms in laboratory settings. The compound’s ability to modulate cyclic adenosine monophosphate levels and influence sympathetic nervous system pathways makes it valuable for cardiovascular and ocular research protocols. Studies investigating selective androgen receptor modulators often benefit from comparative adrenergic receptor research to understand tissue-selective mechanisms.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Brimonidine Tartrate |
| Concentration | 0.15% w/v |
| Formulation | Sterile Ophthalmic Solution |
| Manufacturer | Allergan |
| Storage Conditions | 2-25°C, protect from light |
| Research Applications | Alpha-2 receptor studies, ocular physiology |
Researchers studying compound interactions often cross-reference findings with peptide research compounds to understand receptor selectivity patterns across different molecular classes.
Research Protocol Considerations
Laboratory studies with Alphagan P require careful consideration of storage conditions and handling protocols to maintain compound integrity. The solution should be stored between 2-25°C and protected from direct light exposure during experimental procedures. Research protocols examining brimonidine’s effects on cellular signalling pathways benefit from standardised concentration gradients and controlled environmental conditions. The sterile formulation eliminates contamination variables in cell culture applications, ensuring reliable experimental outcomes. Investigations into ocular pharmacology often incorporate this compound alongside other research materials available through our comprehensive laboratory catalogue. Proper documentation of experimental parameters enhances research reproducibility and supports publication-quality data collection across multiple study designs.
Compliance Notice: Alphagan P Opthalmic Solution 0.15% is supplied exclusively for in-vitro laboratory research purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols and safety measures are maintained during all experimental procedures.
